Lam YW - Search Results

1

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.

Alfaro CL, Lam YW, Simpson J, Ereshefsky L. Alfaro CL, et al. Among authors: lam yw. J Clin Psychopharmacol. 1999 Apr;19(2):155-63. doi: 10.1097/00004714-199904000-00011. J Clin Psychopharmacol. 1999. PMID: 10211917 Clinical Trial.

2

Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

Ereshefsky L, Riesenman C, Lam YW. Ereshefsky L, et al. Among authors: lam yw. Clin Pharmacokinet. 1995;29 Suppl 1:10-8; discussion 18-9. doi: 10.2165/00003088-199500291-00004. Clin Pharmacokinet. 1995. PMID: 8846618 Review.

3

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.

Alfaro CL, Lam YW, Simpson J, Ereshefsky L. Alfaro CL, et al. Among authors: lam yw. J Clin Pharmacol. 2000 Jan;40(1):58-66. doi: 10.1177/00912700022008702. J Clin Pharmacol. 2000. PMID: 10631623 Clinical Trial.

4

Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system.

Ereshefsky L, Riesenman C, Lam YW. Ereshefsky L, et al. Among authors: lam yw. J Clin Psychiatry. 1996;57 Suppl 8:17-24; discussion 25. J Clin Psychiatry. 1996. PMID: 8698676 Review.

5

High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection.

Lam YW, Rodriguez SY. Lam YW, et al. Ther Drug Monit. 1993 Aug;15(4):300-4. doi: 10.1097/00007691-199308000-00007. Ther Drug Monit. 1993. PMID: 8236365

6

Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.

Lam YW, Watkins CE. Lam YW, et al. Clin Pharm. 1993 Jan;12(1):49-52. Clin Pharm. 1993. PMID: 7679064 No abstract available.

7

Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.

Lam YW, Boyd RA, Chin SK, Chang D, Giacomini KM. Lam YW, et al. J Clin Pharmacol. 1991 May;31(5):429-32. doi: 10.1002/j.1552-4604.1991.tb01898.x. J Clin Pharmacol. 1991. PMID: 2050827 Clinical Trial.

8

The pharmacokinetics of teicoplanin in varying degrees of renal function.

Lam YW, Kapusnik-Uner JE, Sachdeva M, Hackbarth C, Gambertoglio JG, Sande MA. Lam YW, et al. Clin Pharmacol Ther. 1990 May;47(5):655-61. doi: 10.1038/clpt.1990.87. Clin Pharmacol Ther. 1990. PMID: 2140543

9

Branded versus generic clozapine: bioavailability comparison and interchangeability issues.

Lam YW, Ereshefsky L, Toney GB, Gonzales C. Lam YW, et al. J Clin Psychiatry. 2001;62 Suppl 5:18-22; discussion 23-4. J Clin Psychiatry. 2001. PMID: 11305844 Clinical Trial.

10

Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Lam YW, Shepherd AM. Lam YW, et al. Clin Pharmacokinet. 1990 Apr;18(4):295-317. doi: 10.2165/00003088-199018040-00003. Clin Pharmacokinet. 1990. PMID: 2182265 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results